Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 2nd Quarter - Termination (No Activity)

ISM THERAPEUTICS

via STRATEGIES 360

2nd Quarter (Apr 1 - June 30) · 2010Posted Jul 19, 2010Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: ISM THERAPEUTICS
Location: Washington · United States of America

Registrant

Firm: STRATEGIES 360
Description: Government affairs
Location: Seattle, Washington, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

ISM THERAPEUTICS — Lobbying — Receipts Report